002907.SZ
华森制药
SZSE · Healthcare · C 制造业 · CN
CNY 14.31
+0.35%Margins
Gross margin
57.5%
EBITDA margin
23.1%
EBIT margin
10.3%
Net margin
7.2%
FCF margin
5.7%
3.3%
Return on equity
2.8%
Return on assets
4.8%
Return on invested capital
0.39x
Asset turnover
CNY 64.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026